About this trial
Black women are more likely than White women to be diagnosed at later stages and to die from breast cancer. Increasing breast cancer screening rates could help improve early detection of and survival from breast cancer. To this end, this study seeks to implement and evaluate a culturally tailored chatbot intervention to increase breast cancer screening and address inequities among Black women using community-based research approaches.
We will conduct a pilot randomized quality improvement trial to test the efficacy of a chatbot outreach intervention, which provides breast cancer screening education and direct links to scheduling, on increasing breast cancer screening completion among Black women who receive primary care at the University of Washington (UW) Medicine. We hypothesize that compared to women who receive usual care, women who receive this novel chatbot outreach will have higher breast cancer screening completion rates at 90-days. In addition to quantitative assessment of chatbot effectiveness, we will also qualitatively evaluate chatbot acceptability, feasibility, and message relevance through interviews with a small group of participants about their experiences with the chatbot.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 40 through 74 years at the time of eligibility assessment.
Assigned female at birth.
An active UW Medicine primary-care patient and included in the UW Medicine population-health breast cancer screening outreach population.
Due for breast cancer screening, defined as having no documented mammogram within the prior 24 months, based on the UW Medicine adaptation of the NCQA HEDIS breast cancer screening measure.
Disqualifiers
History of bilateral mastectomy.
EHR diagnosis or indicator of palliative care, advanced illness, or frailty.
Trial design
Parallel
Treatments tested in this trial
Chatbot
Other interventionChatbot-based outreach that provides breast cancer screening education, allows participants to learn more about screening, and offers direct mammography scheduling through the chatbot
Treatment groups
Trial outcomes
Primary outcomes
Proportion of participants completing BCS 90 days after initial outreach
Secondary outcomes
Proportion of participants who schedule or complete BCS 90 days after initial outreach
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Washington
Lead sponsor
Novartis Pharmaceuticals
Collaborator
National Comprehensive Cancer Network
Collaborator
This trial is not recruiting at the moment. You can still explore other options: